Mayne Pharma Group Limited

ASX:MYX 주식 보고서

시가총액: AU$382.2m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Mayne Pharma Group 관리

관리 기준 확인 1/4

Mayne Pharma Group's CEO는 Shawn O’Brien, Oct2022 에 임명되었습니다 의 임기는 1.67 년입니다. 총 연간 보상은 A$ 1.50M, 44.2% 로 구성됩니다. 44.2% 급여 및 55.8% 보너스(회사 주식 및 옵션 포함). 는 A$ 170.40K 가치에 해당하는 회사 주식의 0.046% 직접 소유합니다. 170.40K. 경영진과 이사회의 평균 재임 기간은 각각 2.4 년과 2.3 년입니다.

주요 정보

Shawn O’Brien

최고 경영자

AU$1.5m

총 보상

CEO 급여 비율44.2%
CEO 임기1.7yrs
CEO 소유권0.05%
경영진 평균 재임 기간2.4yrs
이사회 평균 재임 기간2.3yrs

최근 관리 업데이트

Recent updates

Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Mar 06
Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers

Dec 03
Analysts Just Slashed Their Mayne Pharma Group Limited (ASX:MYX) EPS Numbers

Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?

Dec 01
Is Mayne Pharma Group (ASX:MYX) Using Too Much Debt?

Is Mayne Pharma Group (ASX:MYX) A Risky Investment?

Apr 12
Is Mayne Pharma Group (ASX:MYX) A Risky Investment?

Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

Mar 01
Things Look Grim For Mayne Pharma Group Limited (ASX:MYX) After Today's Downgrade

We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope

Nov 16
We Think Mayne Pharma Group Limited's (ASX:MYX) CEO Compensation Package Needs To Be Put Under A Microscope

Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt

Nov 10
Mayne Pharma Group (ASX:MYX) Is Making Moderate Use Of Debt

Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt

May 17
Mayne Pharma Group (ASX:MYX) Is Carrying A Fair Bit Of Debt

Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?

Mar 22
Is Mayne Pharma Group Limited (ASX:MYX) Trading At A 37% Discount?

How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?

Mar 01
How Many Mayne Pharma Group Limited (ASX:MYX) Shares Did Insiders Buy, In The Last Year?

What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition

Feb 08
What You Need To Know About Mayne Pharma Group Limited's (ASX:MYX) Investor Composition

Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit

Jan 18
Mayne Pharma Group Limited's (ASX:MYX) Shift From Loss To Profit

Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares

Dec 27
Mayne Pharma Group's (ASX:MYX) Shareholders Are Down 75% On Their Shares

Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?

Dec 09
Would Mayne Pharma Group (ASX:MYX) Be Better Off With Less Debt?

A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation

Nov 24
A Quick Analysis On Mayne Pharma Group's (ASX:MYX) CEO Compensation

CEO 보상 분석

Shawn O’Brien 의 보수는 Mayne Pharma Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023n/an/a

-AU$274m

Sep 30 2023n/an/a

-AU$296m

Jun 30 2023AU$2mAU$663k

-AU$317m

보상 대 시장: Shawn 의 총 보상 ($USD 1.00M )은 Australian 시장( $USD 638.90K ).

보상과 수익: Shawn 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Shawn O’Brien (65 yo)

1.7yrs

테뉴어

AU$1,502,156

보상

Mr. Shawn Patrick O'Brien, B.Sc has been CEO, MD & Director at Mayne Pharma Group Limited since October 1, 2022. He serves as the Chief Commercial Advisor at Melanovus Oncology, Inc. Mr. O'Brien is a found...


리더십 팀

이름위치테뉴어보상소유권
Shawn O’Brien
CEO, MD & Director1.7yrsAU$1.50m0.046%
A$ 174.5k
Aaron Gray
Chief Financial Officer1.8yrsAU$1.30m0.016%
A$ 62.6k
Kimberly Parker
Executive VP & General Counsel2.4yrs데이터 없음데이터 없음
Brant Schofield
Executive Vice President of Corporate Development3.4yrsAU$1.29m데이터 없음
Erinn Nathaniel
Director of Global Human Resources1.4yrs데이터 없음데이터 없음
Daniel Moore
Executive Vice President of Commercial4.8yrs데이터 없음데이터 없음
Frank Casty
Executive VP & Global Chief Medical Officer1.4yrs데이터 없음데이터 없음
Brenton Walter
Financial Controller19.9yrs데이터 없음데이터 없음
Laura Loftus
Associate General Counsel & Company Secretary4.3yrs데이터 없음데이터 없음

2.4yrs

평균 재임 기간

경험이 풍부한 관리: MYX 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Shawn O’Brien
CEO, MD & Director1.7yrsAU$1.50m0.046%
A$ 174.5k
Frank Condella
Independent Non-Executive Chairman6.1yrsAU$297.04k0.081%
A$ 310.5k
Bruce Robinson
Independent Non-Executive Director9.8yrsAU$166.43k0.039%
A$ 149.5k
Patrick Blake
Independent Non-Executive Director6yrsAU$212.39k0.027%
A$ 104.1k
Ann Custin
Independent Non-Executive Director2.3yrsAU$212.39k0.026%
A$ 100.6k
Kathryn MacFarlane
Independent Non-Executive Director2.3yrsAU$212.42k0.047%
A$ 179.0k
Anne Lockwood
Directorless than a year데이터 없음데이터 없음
David Petrie
Independent Non-Executive Director1.8yrsAU$137.96k데이터 없음

2.3yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: MYX 의 이사회경험(평균 재직 기간 2.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.